Travere Therapeutics, Inc. (NASDAQ:TVTX) Given Average Recommendation of “Moderate Buy” by Brokerages

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen analysts that are covering the firm, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year […]

Leave a Reply

Your email address will not be published.

Previous post Brokerages Set United Therapeutics Co. (NASDAQ:UTHR) Target Price at $334.45
Next post PagSeguro Digital Ltd. (NYSE:PAGS) Receives Average Recommendation of “Moderate Buy” from Brokerages